Skip to content

Frequency Foundation

Twice the Energy with Half the Stress

Why Cancer and Diabetes May Have a Similar Etiology

Diabetes and Cancer: How The Two Are Connected

Diabetes and cancer are two of the leading causes of death worldwide. The mere mention of either disease can strike fear in anyone’s heart. It is because no one is immune from either disease. Young or old, male or female, everyone is at risk. The statistics released by the International Diabetes Federation reveals the growing threat of diabetes worldwide with 425 million adults affected by it in 2017. An additional 1,106,500 children were afflicted. The forecast for diabetes cases gets worse. The report suggests the number would go up to 629 million by 2045.

The figures for cancer are equally alarming. According to the World Health Organization (WHO), cancer is the cause of 1 in 6 deaths worldwide. It accounted for 8.8 million deaths in 2015. The grim forecast for new cancer cases in the next 20 years points to an increase of almost 70%.

Yet what could be worse than diabetes or cancer? Perhaps, it would be the discovery of a possible link between the two conditions. While 1.6 million deaths every year can be linked to diabetes, it is important to clarify how the two may intertwine. 2

The Link Between Diabetes And Cancer

A report from the American Diabetes Association together with the American Cancer Society looked into the connection between diabetes and cancer back in 2010.3 Based on its findings, it appears their link shows an increased risk of certain cancers as a consequence of diabetes and its complications.


From a frequency perspective virtually all Americas have an e coli infection of the pancreas impacting mitochondrial function which affects insulin production and causes blood sugar problems. Cancer is a disease of dysfunctional mitochondria caused primarily by the Rife BX BY organism (bacillus licheniformis). Failing mitochondria cause energy production to go anerobic leading to DNA mutations. It makes sense that the two are linked as mitochondria are failing in both cases.

Using the Immune System to Eradicate Cancer

Eradication of spontaneous malignancy by local immunotherapy

Idit Sagiv-Barfi1Debra K. Czerwinski1Shoshana Levy1Israt S. Alam2Aaron T. Mayer2Sanjiv S. Gambhir2 and Ronald Levy1,*
Science Translational Medicine  31 Jan 2018: Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488  PDF

Deliver locally, act globally

Mobilizing endogenous T cells to fight tumors is the goal of many immunotherapies. Sagiv-Barfi et al. investigated a combination therapy in multiple types of mouse cancer models that could provide sustainable antitumor immunity. Specifically, they combined intratumoral delivery of a TLR9 ligand with OX40 activation to ramp up T cell responses. This dual immunotherapy led to shrinkage of distant tumors and long-term survival of the animals, even in a stringent spontaneous tumor model. Both of these stimuli are in clinical trials as single agents and could likely be combined at great benefit for cancer patients.

Abstract

It has recently become apparent that the immune system can cure cancer. In some of these strategies, the antigen targets are preidentified and therapies are custom-made against these targets. In others, antibodies are used to remove the brakes of the immune system, allowing preexisting T cells to attack cancer cells. We have used another noncustomized approach called in situ vaccination. Immunoenhancing agents are injected locally into one site of tumor, thereby triggering a T cell immune response locally that then attacks cancer throughout the body. We have used a screening strategy in which the same syngeneic tumor is implanted at two separate sites in the body. One tumor is then injected with the test agents, and the resulting immune response is detected by the regression of the distant, untreated tumor. Using this assay, the combination of unmethylated CG–enriched oligodeoxynucleotide (CpG)—a Toll-like receptor 9 (TLR9) ligand—and anti-OX40 antibody provided the most impressive results. TLRs are components of the innate immune system that recognize molecular patterns on pathogens. Low doses of CpG injected into a tumor induce the expression of OX40 on CD4+ T cells in the microenvironment in mouse or human tumors. An agonistic anti-OX40 antibody can then trigger a T cell immune response, which is specific to the antigens of the injected tumor. Remarkably, this combination of a TLR ligand and an anti-OX40 antibody can cure multiple types of cancer and prevent spontaneous genetically driven cancers.

Why this Doctor Doesn’t Get a Flu Shot

 The Cochran Collaboration disagrees with these “facts”!

Update: The New England Journal of Medicine reports 10% effectiveness for 1917-1918 flu shot.

Every once in a while a good doctor starts asking a lot of questions. Check out one of the best articles on the flu shot. The entire article is worth reading. Here is the medical summary:

“The best place to start a search for accurate medical information is usually the Cochrane database.

“Cochrane is a non-profit research organization based in the United Kingdom and they tend to be considered the gold standard in scientific medical research. Their reviews of the medical literature are comprehensive and carefully peer-reviewed.

“As my colleague, Mark Hyman, M.D., explains in an article, Flu Shot: Harmful or Helpful?: “One very reliable way to determine the effectiveness of the flu shot is to look at the database analysis presented by The Cochrane Collaboration, an independent group of scientists who have no link to any industry or government agencies.”

“So what does Cochrane have to say about the flu vaccine?

  1. It’s not effective for children under age 18 or for adults over 65.
  2. Between ages 18 to 65, it is only 30-50% effective in an average year (which means it fails between 50-70% of the time) and up to 80% in a perfectly matched year (a much lower number than most vaccines).
  3. There is no decrease in flu transmission rate or hospitalization rate for people who have gotten the flu vaccine.

“Ut oh.

“Here is the Cochrane review’s results and conclusions so you can read them yourself:

MAIN RESULTS: We included 50 reports. Forty (59 sub-studies) were clinical trials of over 70,000 people. Eight were comparative non-RCTs and assessed serious harms. Two were reports of harms which could not be introduced in the data analysis. In the relatively uncommon circumstance of vaccine matching the viral circulating strain and high circulation, 4% of unvaccinated people versus 1% of vaccinated people developed influenza symptoms (risk difference (RD) 3%, 95% confidence interval (CI) 2% to 5%). The corresponding figures for poor vaccine matching were 2% and 1% (RD 1, 95% CI 0% to 3%). These differences were not likely to be due to chance. Vaccination had a modest effect on time off work and had no effect on hospital admissions or complication rates. Inactivated vaccines caused local harms and an estimated 1.6 additional cases of Guillain-Barré Syndrome per million vaccinations. The harms evidence base is limited.

Hundreds of Millions Exposed to Carcinogenic SV40 Virus

Frequency Research Foundation continues to find SV40 vaccine in malignant cells. Strains of the virus have proliferated and promote cancer wherever found. Many new strains discovered in 1917 will be published here. This is the most studied virus in human history. See Bookchin and Schumacher’s exellent book “The Virus and the Vaccine.”

Vaccine scandal revives cancer fear

19:00 07 July 04 New Scientist

Many millions more people than previously thought might have been given polio vaccine contaminated with a monkey virus linked to cancer.

It has been known since 1960 that early doses of polio vaccine were widely contaminated with simian virus 40, or SV40, which infects macaque monkeys. Tens of millions of people in the US and an unknown number in other countries, including the UK, Australia and the former Soviet Union, may have been exposed prior to 1963.

The contamination occurred because the kidney cells the vaccine virus was grown in came from monkeys infected with SV40. Health officials say the problem was eliminated after 1963.

Now Michele Carbone of Loyola University Medical Center in Chicago has announced results that suggest the Soviet polio vaccine was contaminated after 1963, possibly until the early 1980s. “Is there infectious virus? The short answer is, yes,” Carbone told the Vaccine Cell Substrate Conference 2004 in Rockville, Maryland, last week.

The vaccine was almost certainly used throughout the Soviet bloc and probably exported to China, Japan and several countries in Africa. That means hundreds of millions could have been exposed to SV40 after 1963.

[trx_button type=”square” style=”filled” size=”small” align=”left” link=”https://www.frequencyfoundation.com/product/sv40/” popup=”no” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]SV40 Frequencies[/trx_button]

 

 

The SV40 Cancer Foundation provides an awesome summary of the history of SV40 and the polio vaccine. Here is a short excerpt:

SV40—A Human Carcinogen

By 1999, numerous pathologists, microbiologists, and virologists throughout the world had detected SV40 in a variety of human cancers such as brain tumors[66] including medulloblastomas,[67] bone cancers,[68] and mesotheliomas[69] a fatal lung cancer. These were the very same cancers that were created when SV40 was introduced into animals.[70] The advent of Polymerase Chain Reaction (PCR) technology that could identify the genetic code of specific strands of DNA demonstrated with precision that it was this monkey virus that was being detected in human cancers and no other.[71] Moreover, the rates of these particular cancers had steadily increased over the last few decades.[72] The question that had been left unanswered for almost four decades now faced scientists again—was SV40 responsible for causing or contributing to human cancers?

Over the last forty years since its discovery, SV40 had become one of the most widely studied and best understood viruses in microbiology.[73] It was routinely used to create human cancers in the laboratory in order to test cancer therapies.[74] In addition, it is now known how this virus caused cancer on a molecular level. After careful study documented in peer reviewed publications, leaders in SV40 research announced that SV40 was a class 2A human carcinogen.[75]

The Government’s Response

Nonetheless, the various United States government agencies such as the Centers for Disease Control (CDC) and National Cancer Institute (NCI) disputed these conclusions. According to the CDC, “SV40 virus has been found in certain types of cancer in humans, but it has not been determined that SV40 causes these cancers.”[76] According to the National Intsitutes of Health (NIH), “the NCI is continuing to evaluate the possible link between SV40 infection and human cancers.”[77] A question has been raised whether this continuing evaluation is being performed with complete scientific integrity. One article written by an attorney and published in a peer reviewed scientific journal describes how the NCI deliberately compromised a study that would have demonstrated the association between SV40 and mesothelioma.[78]

While the United States government continues to evaluate whether or not SV40 represents a public health threat and whether SV40 is a human carcinogen, several scientists at the NCI concluded that SV40 contributed to the formation of mesotheliomas.[79] In fact, the federal government has licensed technology to target SV40 in the treatment of human mesotheliomas.[80]

SV40 and the Public Health

Despite the government’s foot dragging, in the last several years, scientists from around the world have made startling and disturbing discoveries. They have found SV40 antibodies in a significant percentage of people including children who were too young to receive the SV40 contaminated vaccines of the early 1960’s.[81] They have also discovered that cancers with SV40 are less likely to be responsive to chemotherapy and radiation because SV40 interferes with the genes necessary for cancer cells to die when they are exposed to chemo or radiation therapy.[82]

The Institute of Medicine Report

In July 2002, the National Academy of Science Institute of Medicine (IOM) Immunization Safety Committee convened a study into SV40 and cancer which culminated in a report published in October 2002. According to the IOM report “SV40 Contamination of Polio Vaccine and Cancer”:

The committee concludes that the biological evidence is strong that SV40 is a transforming [i.e., cancer-causing] virus, . . . that the biological evidence is of moderate strength that SV40 exposure could lead to cancer in humans under natural conditions, [and] that the biological evidence is of moderate strength that SV40 exposure from the polio vaccine is related to SV40 infection in humans.[83]

BEC 5 Curaderm – A Solution for Basal Cell Carcinoma

The Australians who get a lot of basal cell carcinomas have developed a cream based on egg-plant extract that targets receptor sites on cancer cells and kills them. It has been tested in clinical trials and eliminates virtually 100% of basal cell tumors and some other cancers. This is a great alternative to surgery. See Cancer Letters clinical trial.

BEC 5 Curaderm is widely available without a prescription. It does demand some patience as it takes some weeks for the body to heal after repeated application.

Frequencies alone can eliminate basal cell carcinomas but it is a lot easier in combination with Curaderm. The advantage of frequencies it that they target the underlying cause of the cancer so it is possible to eliminate recurrence and new basal cell carcinomas.

Frequency Research Foundation subscribers have access to extensive sets of frequencies useful with cancer. It is advisable to get a Photoanalysis consultation to use them effectively.

As always consult with your own physician if there are problems. My physician showed me his own basal cell that he cured with Curaderm during my last patient visit.

Marburg Virus – Version 1.0

The Beauty of the Marburg Virus

Cosmos Magazine – 14 April 2017

Photo; The University of Texas at Galveston

“The Marburg virus, a relative of Ebola, causes a haemorrhagic fever that kills around 80% of people who are infected. Though the virus is rare, there is currently no effective treatment. Even in those who survive and undergo an apparently complete recovery, the virus may re-emerge in later life or be passed on to children.


Almost half a dozen strains of the Marburg Virus have been sequenced. Some were circulating in the flu several years ago.

A client had severe headaches for over a year. Frequencies were used for biofilms, viruses, parasites, and original Rife frequencies for the organism that causes cancer. Some periodic relief but no cure. Only when the Marburg Virus was identified did all symptoms disappear within a day.

 

Science That Works: Bioelectronic Medicine

20 years ago the Frequency Research Foundation started talking about electronic medicine. Scientific American reviews the latest research and calls it bioelectronic medicine. It works because electronic frequencies can cause the body to manufacture drugs.

[trx_image url=”https://www.frequencyfoundation.com/wp-content/uploads/2017/03/Scientific_American_-_March_2015-300×250.jpg” align=”left” shape=”square” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]

It takes 20 years for conventional science to catch up with research. You can send an electronic signature that conveys the same information that the physical drug provides without many of the negative side effects. The electronic signature of DNA can be sent over the internet and DNA in a distance lab will self-construct in a test tube with the basic ingredients. CRISPR which does DNA editing creates many errors when done with viruses yet electromagnetic frequencies allow much more precise gene editing. All of these findings are published in leading medical journals. Most physicians are not even aware of them and none of them have reached the clinical trial phase at the time of this writing.

The Spooky 2 site offers an easy way to convert the molecular weight of a drug to frequencies without knowing the details of the formulas required. Spooky was motivated by early Frequency Research Foundation work. Any substance with a known molecular weight can be converted into a frequency for subscribers. Also any Frequency Research Foundation data sets can be converted to Spooky format on this web site.

You might see electronic drugs in Scientific American in about 20 years, maybe sooner.

Mycoplasma Fementans Incognitus Frequencies Version 1.0

United States Patent 5,242,820
Lo September 7, 1993

Pathogenic Mycoplasma (Mycoplasma Fermentans Incognitus)

Abstract
The invention relates to a novel pathogenic mycoplasma isolated from patients with Acquired Immune Deficiency Syndrome (AIDS) and its use in detecting antibodies in sera of AIDS patients, patients with AIDS-related complex (ARC) or patients dying of diseases and symptoms resembling AIDS diseases. The invention further relates to specific DNA sequences, antibodies against the pathogenic mycoplasma, and their use in detecting DNA or antigens of the pathogenic mycoplasma or other genetically and serologically closely related mycoplasmas in infected tissue of patients with AIDS or ARC or patients dying of symptoms resembling AIDS diseases. The invention still further relates to a variety of different forms of vaccine against mycoplasma infection in humans and/or animals.


Inventors: Lo; Shyh-Ching (Potomac, MD)
Assignee: American Registry of Pathology (Washington, DC)
Family ID: 27401851
Appl. No.: 07/710,361
Filed: June 6, 1991

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
265920 Nov 2, 1988
875535 Jun 18, 1986

Other References

Marquart et al (1985) Mycoplasma-Like Structures . . . Eur J Clin Microbiol 4(1):73-74. .
Lo et al (1989) A Novel Virus-like Infectious Agent . . . Am J Trop Med Hyg 40(2):213-226. .
Lo et al (1989) Identification of M Incognitus . . . Am. J. Trop-Med. Hyg 41(5):601-616. .
Lo et al (1989) Association of the Virus-like Agent . . . Am J Trop Med Hyg 41(3):364-376. .
Lo et al (1989) Fatal Infection of Silvered Leaf Monkeys . . . Am. T Trop Med Hyg 40(4):399-409. .
Lo et al (1989) Virus-like Infectious Agent . . . Am J Trop Med Hyg 41(5):586-600. .
Marquart et al (Feb. 1985) Abstract Only Eur J Clin Microbiol 4(1):73-74. .
Hu et al (1990) Gene 93:67-72..

Primary Examiner: Nucker; Christine M.
Assistant Examiner: Preston; D. R.
Attorney, Agent or Firm: Venable, Baetjer, Howard & Civiletti


Government Interests
The invention described herein was made in the course of work under a grant or award from the United States Department of the Army.


Parent Case Text
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a continuation-in-part of U.S. patent application Ser. No. 265,920, filed Nov. 2, 1988, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 875,535, filed Jun. 18, 1986, now abandoned.


Claims
What is claimed is:
1. A biologically pure mycoplasma isolated from tissues of patients with AIDS comprising the mycoplasma produced by the cell line ATCC No. CRL 9127.
2. A biologically pure mycoplasma having the identifying characteristics of M. fermentans incognitus, ATCC 53949.


Description
BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to a novel strain of mycoplasma isolated from a patient with AIDS. The mycoplasma is closely related to a species of human mycoplasma, M. fermentans. Upon characterization of this mycoplasma, it may be classified as a unique strain within the species M. fermentans incognitus. This novel strain of nycoplasma is referred to hereinafter as the incognitus strain or M. fermentans incognitus.

The invention also relates to use of the mycoplasma M. fermentans incognitus as well as all strains of M. fermentans in detecting specific antibodies in sera of patients with AIDS or an acute fulminant systemic disease and/or animals and its use as a vaccine against infection by the mycoplasma. The invention further relates to incognitus strain-specific antibodies and cross-reactive which later break up into individual cells that are capable of passing through membrane filters of pore size 0.45 .mu.m or even 0.22 .mu.m.


Those with Lyme disease may already be aware of this coinfection. It appears to be circulating with the 2017 flu causing extended periods of serious illness. Frequencies are available to subscribers.

Pseudoscience: Half of the Medical Literature?

Richard Horton is the editor of one of the leading medical journals in the world, The Lancet. Here is what he reported from a UK symposium on the reproducibility and reliability of biomedical research:

“A lot of what is published is incorrect.” I’m not allowed to say who made this remark because we were asked to observe Chatham House rules. We were also asked not to take photographs of slides. Those who worked for government agencies pleaded that their comments especially remain unquoted, since the forthcoming UK election meant they were living in “purdah”—a chilling state where severe restrictions on freedom of speech are placed on anyone on the government’s payroll. Why the paranoid concern for secrecy and non-attribution? Because this symposium—on the reproducibility and reliability of biomedical research, held at the Wellcome Trust in London last week—touched on one of the most sensitive issues in science today: the idea that something has gone fundamentally wrong with one of our greatest human creations. * The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue.”

Click here for the full article …

Hepatitis C Frequencies

Hepatitis C electron micrograph – Wikipedia

The swine flu virus complex circulated many viruses and bacteria including Hepatitis C. If you were infected with the Swine flu you may have a latent Hepatitis C infection. Frequencies for Hepatitis C are regularly updated. Always us the latest frequencies for best results.

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver.[1] During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. The virus persists in the liver in about 75% to 85% of those initially infected. Early on chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis.[2] In some cases, those with cirrhosis will develop complications such as liver failure, liver cancer, or esophageal and gastric varices.[1]

HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions.[2][3] Using blood screening, the risk from a transfusion is less than one per two million.[2] It may also be spread from an infected mother to her baby during birth.[2] It is not spread by superficial contact.[4] It is one of five known hepatitis viruses: A, B, C, D, and E.[5] Diagnosis is by blood testing to look for either antibodies to the virus or its RNA. Testing is recommended in all people who are at risk.[2]

There is no vaccine against hepatitis C.[2][6] Prevention includes harm reduction efforts among people who use intravenous drugs and testing donated blood.[4] Chronic infection can be cured about 90% of the time with treatments that include the medications sofosbuvir or simeprevir.[2][4] Previous to this a combination of peginterferon and ribavirin was used which had a cure rate around 50% and greater side effects. Getting access to the newer treatments however can be expensive.[4] Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation.[7]

An estimated 130–200 million people worldwide are infected with hepatitis C.[4][8][9] In 2013 about 11 million new cases occurred.[10] It occurs most commonly in Africa and Central and East Asia.[4] About 343,000 deaths due to liver cancer and 358,000 deaths due to cirrhosis occurred in 2013 due to hepatitis C.[11] The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989.[12] Hepatitis C infects only humans and chimpanzees.[13] (from Wikipedia)